172 related articles for article (PubMed ID: 22813987)
1. Contribution of the MexXY multidrug efflux pump and other chromosomal mechanisms on aminoglycoside resistance in Pseudomonas aeruginosa isolates from canine and feline infections.
Poonsuk K; Chuanchuen R
J Vet Med Sci; 2012 Dec; 74(12):1575-82. PubMed ID: 22813987
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.
Poonsuk K; Tribuddharat C; Chuanchuen R
Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
[TBL] [Abstract][Full Text] [Related]
4. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside resistance in
Thacharodi A; Lamont IL
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708991
[No Abstract] [Full Text] [Related]
6. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
Singh M; Yau YCW; Wang S; Waters V; Kumar A
Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
Sobel ML; McKay GA; Poole K
Antimicrob Agents Chemother; 2003 Oct; 47(10):3202-7. PubMed ID: 14506031
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa.
Fraud S; Poole K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1068-74. PubMed ID: 21173187
[TBL] [Abstract][Full Text] [Related]
9. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
[TBL] [Abstract][Full Text] [Related]
10. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
Morita Y; Tomida J; Kawamura Y
Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
[TBL] [Abstract][Full Text] [Related]
11. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
Islam S; Jalal S; Wretlind B
Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
[TBL] [Abstract][Full Text] [Related]
14. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.
Guénard S; Muller C; Monlezun L; Benas P; Broutin I; Jeannot K; Plésiat P
Antimicrob Agents Chemother; 2014; 58(1):221-8. PubMed ID: 24145539
[TBL] [Abstract][Full Text] [Related]
15. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
Muller C; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.
Lau CH; Fraud S; Jones M; Peterson SN; Poole K
Antimicrob Agents Chemother; 2012 Oct; 56(10):5171-9. PubMed ID: 22825121
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Pseudomonas aeruginosa isolates from dogs and cats in Japan: current status of antimicrobial resistance and prevailing resistance mechanisms.
Harada K; Arima S; Niina A; Kataoka Y; Takahashi T
Microbiol Immunol; 2012 Feb; 56(2):123-7. PubMed ID: 22188523
[TBL] [Abstract][Full Text] [Related]
18. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
19. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
El'Garch F; Jeannot K; Hocquet D; Llanes-Barakat C; Plésiat P
Antimicrob Agents Chemother; 2007 Mar; 51(3):1016-21. PubMed ID: 17194835
[TBL] [Abstract][Full Text] [Related]
20. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Suresh M; Nithya N; Jayasree PR; Vimal KP; Manish Kumar PR
World J Microbiol Biotechnol; 2018 May; 34(6):83. PubMed ID: 29846800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
